| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A combination of nirmatrelvir and ombitasvir boosts inhibition of SARS-CoV-2 replication
|
Moon, Christopher
|
|
|
225 |
C |
p.
|
artikel
|
| 2 |
A virus-like particle candidate vaccine based on CRISPR/Cas9 gene editing technology elicits broad-spectrum protection against SARS-CoV-2
|
Wang, Weiqi
|
|
|
225 |
C |
p.
|
artikel
|
| 3 |
Azapeptides with unique covalent warheads as SARS-CoV-2 main protease inhibitors
|
Khatua, Kaustav
|
|
|
225 |
C |
p.
|
artikel
|
| 4 |
Broad antibody and T cell responses to Ebola, Sudan, and Bundibugyo ebolaviruses using mono- and multi-valent adjuvanted glycoprotein vaccines
|
Felgner, Jiin
|
|
|
225 |
C |
p.
|
artikel
|
| 5 |
Caffeic acid phenethyl ester: an effective antiviral agent against porcine reproductive and Respiratory Syndrome Virus
|
Cui, Zhanding
|
|
|
225 |
C |
p.
|
artikel
|
| 6 |
Construction of exosome-loaded LL-37 and its protection against zika virus infection
|
Wang, Chen
|
|
|
225 |
C |
p.
|
artikel
|
| 7 |
Corrigendum to “Avasimibe can cooperate with a DC-targeting and integration-deficient lentivector to induce stronger HBV specific T cytotoxic response by regulating cholesterol metabolism” Antiviral Res. 2023 Aug:216:105662]
|
Ma, Siyuan
|
|
|
225 |
C |
p.
|
artikel
|
| 8 |
DDX20 positively regulates the interferon pathway to inhibit viral infection
|
Chen, Zhiqiang
|
|
|
225 |
C |
p.
|
artikel
|
| 9 |
β-D-N4-hydroxycytidine (NHC, EIDD-1931) inhibits chikungunya virus replication in mosquito cells and ex vivo Aedes aegypti guts, but not when ingested during blood-feeding
|
Rosales-Rosas, Ana Lucia
|
|
|
225 |
C |
p.
|
artikel
|
| 10 |
Early application of IFNγ mediated the persistence of HBV in an HBV mouse model
|
Song, Jingjiao
|
|
|
225 |
C |
p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
|
225 |
C |
p.
|
artikel
|
| 12 |
Glucocorticoid receptor and specificity protein 1 (Sp1) or Sp3, but not the antibiotic Mithramycin A, stimulates human alphaherpesvirus 1 (HSV-1) replication
|
El-Mayet, Fouad S.
|
|
|
225 |
C |
p.
|
artikel
|
| 13 |
Glycan-directed SARS-CoV-2 inhibition by leek extract and lectins with insights into the mode-of-action of Concanavalin A
|
Klevanski, Maja
|
|
|
225 |
C |
p.
|
artikel
|
| 14 |
Nanomolar anti-SARS-CoV-2 Omicron activity of the host-directed TMPRSS2 inhibitor N-0385 and synergistic action with direct-acting antivirals
|
Pérez-Vargas, Jimena
|
|
|
225 |
C |
p.
|
artikel
|
| 15 |
New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses
|
Siniavin, Andrei E.
|
|
|
225 |
C |
p.
|
artikel
|
| 16 |
Preclinical animal models to evaluate therapeutic antiviral antibodies
|
De Meyer, Amse
|
|
|
225 |
C |
p.
|
artikel
|
| 17 |
Progress in novel delivery technologies to improve efficacy of therapeutic antibodies
|
Sun, Wenli
|
|
|
225 |
C |
p.
|
artikel
|
| 18 |
Supplementation of seasonal vaccine with multi-subtype neuraminidase and M2 ectodomain virus-like particle improves protection against homologous and heterologous influenza viruses in aged mice
|
Raha, Jannatul Ruhan
|
|
|
225 |
C |
p.
|
artikel
|
| 19 |
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistance
|
Schreiber, André
|
|
|
225 |
C |
p.
|
artikel
|
| 20 |
Third International Conference on Crimean-Congo Hemorrhagic Fever in Thessaloniki, Greece, September 19–21, 2023
|
Welch, Stephen R.
|
|
|
225 |
C |
p.
|
artikel
|
Tijdschrift beschrijving